Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases

Dirk Rades, Liesa Dziggel, Tiina Haatanen, Theo Veninga, Radka Lohynska, Jürgen Dunst, Steven E. Schild

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Purpose: To create and validate scoring systems for intracerebral control (IC) and overall survival (OS) of patients irradiated for brain metastases. Methods and Materials: In this study, 1,797 patients were randomly assigned to the test (n = 1,198) or the validation group (n = 599). Two scoring systems were developed, one for IC and another for OS. The scores included prognostic factors found significant on multivariate analyses. Age, performance status, extracerebral metastases, interval tumor diagnosis to RT, and number of brain metastases were associated with OS. Tumor type, performance status, interval, and number of brain metastases were associated with IC. The score for each factor was determined by dividing the 6-month IC or OS rate (given in percent) by 10. The total score represented the sum of the scores for each factor. The score groups of the test group were compared with the corresponding score groups of the validation group. Results: In the test group, 6-month IC rates were 17% for 14-18 points, 49% for 19-23 points, and 77% for 24-27 points (p < 0.0001). IC rates in the validation group were 19%, 52%, and 77%, respectively (p < 0.0001). In the test group, 6-month OS rates were 9% for 15-19 points, 41% for 20-25 points, and 78% for 26-30 points (p < 0.0001). OS rates in the validation group were 7%, 39%, and 79%, respectively (p < 0.0001). Conclusions: Patients irradiated for brain metastases can be given scores to estimate OS and IC. IC and OS rates of the validation group were similar to the test group demonstrating the validity and reproducibility of both scores.

Original languageEnglish (US)
Pages (from-to)1122-1127
Number of pages6
JournalInternational Journal of Radiation Oncology Biology Physics
Volume80
Issue number4
DOIs
StatePublished - Jul 15 2011

Fingerprint

scoring
metastasis
brain
Survival Rate
Neoplasm Metastasis
Brain
estimates
Survival
Neoplasms
Multivariate Analysis
tumors
intervals

Keywords

  • Brain metastases
  • Local control
  • Prognostic scores
  • Radiation therapy
  • Survival

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases. / Rades, Dirk; Dziggel, Liesa; Haatanen, Tiina; Veninga, Theo; Lohynska, Radka; Dunst, Jürgen; Schild, Steven E.

In: International Journal of Radiation Oncology Biology Physics, Vol. 80, No. 4, 15.07.2011, p. 1122-1127.

Research output: Contribution to journalArticle

Rades, Dirk ; Dziggel, Liesa ; Haatanen, Tiina ; Veninga, Theo ; Lohynska, Radka ; Dunst, Jürgen ; Schild, Steven E. / Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases. In: International Journal of Radiation Oncology Biology Physics. 2011 ; Vol. 80, No. 4. pp. 1122-1127.
@article{333bee11cc7244808bbcf95181e1dacf,
title = "Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases",
abstract = "Purpose: To create and validate scoring systems for intracerebral control (IC) and overall survival (OS) of patients irradiated for brain metastases. Methods and Materials: In this study, 1,797 patients were randomly assigned to the test (n = 1,198) or the validation group (n = 599). Two scoring systems were developed, one for IC and another for OS. The scores included prognostic factors found significant on multivariate analyses. Age, performance status, extracerebral metastases, interval tumor diagnosis to RT, and number of brain metastases were associated with OS. Tumor type, performance status, interval, and number of brain metastases were associated with IC. The score for each factor was determined by dividing the 6-month IC or OS rate (given in percent) by 10. The total score represented the sum of the scores for each factor. The score groups of the test group were compared with the corresponding score groups of the validation group. Results: In the test group, 6-month IC rates were 17{\%} for 14-18 points, 49{\%} for 19-23 points, and 77{\%} for 24-27 points (p < 0.0001). IC rates in the validation group were 19{\%}, 52{\%}, and 77{\%}, respectively (p < 0.0001). In the test group, 6-month OS rates were 9{\%} for 15-19 points, 41{\%} for 20-25 points, and 78{\%} for 26-30 points (p < 0.0001). OS rates in the validation group were 7{\%}, 39{\%}, and 79{\%}, respectively (p < 0.0001). Conclusions: Patients irradiated for brain metastases can be given scores to estimate OS and IC. IC and OS rates of the validation group were similar to the test group demonstrating the validity and reproducibility of both scores.",
keywords = "Brain metastases, Local control, Prognostic scores, Radiation therapy, Survival",
author = "Dirk Rades and Liesa Dziggel and Tiina Haatanen and Theo Veninga and Radka Lohynska and J{\"u}rgen Dunst and Schild, {Steven E.}",
year = "2011",
month = "7",
day = "15",
doi = "10.1016/j.ijrobp.2010.03.031",
language = "English (US)",
volume = "80",
pages = "1122--1127",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases

AU - Rades, Dirk

AU - Dziggel, Liesa

AU - Haatanen, Tiina

AU - Veninga, Theo

AU - Lohynska, Radka

AU - Dunst, Jürgen

AU - Schild, Steven E.

PY - 2011/7/15

Y1 - 2011/7/15

N2 - Purpose: To create and validate scoring systems for intracerebral control (IC) and overall survival (OS) of patients irradiated for brain metastases. Methods and Materials: In this study, 1,797 patients were randomly assigned to the test (n = 1,198) or the validation group (n = 599). Two scoring systems were developed, one for IC and another for OS. The scores included prognostic factors found significant on multivariate analyses. Age, performance status, extracerebral metastases, interval tumor diagnosis to RT, and number of brain metastases were associated with OS. Tumor type, performance status, interval, and number of brain metastases were associated with IC. The score for each factor was determined by dividing the 6-month IC or OS rate (given in percent) by 10. The total score represented the sum of the scores for each factor. The score groups of the test group were compared with the corresponding score groups of the validation group. Results: In the test group, 6-month IC rates were 17% for 14-18 points, 49% for 19-23 points, and 77% for 24-27 points (p < 0.0001). IC rates in the validation group were 19%, 52%, and 77%, respectively (p < 0.0001). In the test group, 6-month OS rates were 9% for 15-19 points, 41% for 20-25 points, and 78% for 26-30 points (p < 0.0001). OS rates in the validation group were 7%, 39%, and 79%, respectively (p < 0.0001). Conclusions: Patients irradiated for brain metastases can be given scores to estimate OS and IC. IC and OS rates of the validation group were similar to the test group demonstrating the validity and reproducibility of both scores.

AB - Purpose: To create and validate scoring systems for intracerebral control (IC) and overall survival (OS) of patients irradiated for brain metastases. Methods and Materials: In this study, 1,797 patients were randomly assigned to the test (n = 1,198) or the validation group (n = 599). Two scoring systems were developed, one for IC and another for OS. The scores included prognostic factors found significant on multivariate analyses. Age, performance status, extracerebral metastases, interval tumor diagnosis to RT, and number of brain metastases were associated with OS. Tumor type, performance status, interval, and number of brain metastases were associated with IC. The score for each factor was determined by dividing the 6-month IC or OS rate (given in percent) by 10. The total score represented the sum of the scores for each factor. The score groups of the test group were compared with the corresponding score groups of the validation group. Results: In the test group, 6-month IC rates were 17% for 14-18 points, 49% for 19-23 points, and 77% for 24-27 points (p < 0.0001). IC rates in the validation group were 19%, 52%, and 77%, respectively (p < 0.0001). In the test group, 6-month OS rates were 9% for 15-19 points, 41% for 20-25 points, and 78% for 26-30 points (p < 0.0001). OS rates in the validation group were 7%, 39%, and 79%, respectively (p < 0.0001). Conclusions: Patients irradiated for brain metastases can be given scores to estimate OS and IC. IC and OS rates of the validation group were similar to the test group demonstrating the validity and reproducibility of both scores.

KW - Brain metastases

KW - Local control

KW - Prognostic scores

KW - Radiation therapy

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=79959336139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959336139&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2010.03.031

DO - 10.1016/j.ijrobp.2010.03.031

M3 - Article

C2 - 20638188

AN - SCOPUS:79959336139

VL - 80

SP - 1122

EP - 1127

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 4

ER -